Thesing Carisha S, Bot Mariska, Milaneschi Yuri, Giltay Erik J, Penninx Brenda W J H
Amsterdam UMC, Vrije Universiteit, Psychiatry, Amsterdam Public Health Research Institute, the Netherlands.
Amsterdam UMC, Vrije Universiteit, Psychiatry, Amsterdam Public Health Research Institute, the Netherlands.
J Psychiatr Res. 2020 May;124:1-8. doi: 10.1016/j.jpsychires.2020.02.011. Epub 2020 Feb 16.
Temporality of the association of low omega-3 polyunsaturated fatty acid (n-3 PUFA) plasma levels with depression remains questionable. To determine the underlying nature of these associations, this study examined the bidirectional longitudinal associations of n-3 PUFA plasma levels with (presence, onset and course of) depressive disorders and symptoms.
Baseline (n = 2912, 28.6% with current depressive disorder) and 6-year follow-up data (n = 1966, 13.0% with current depressive disorder) of the Netherlands Study of Depression and Anxiety (NESDA) were used. Depression diagnoses and symptoms were based on psychiatric interviews and self-report questionnaires. N-3 PUFA levels (ratio of total fatty acids (mmol%)), were assessed using nuclear magnetic resonance.
Using two waves of data, n-3 PUFA levels were lower among depressed persons, as compared to healthy controls (Beta = -0.047, SE = 0.011, p < .001). Nevertheless, baseline n-3 PUFA levels were not consistently associated with subsequent change in depressive symptoms, onset or remission of depressive disorders over 6 years. Furthermore, the difference in n-3 PUFA levels detected at baseline between depressed and non-depressed participants tended to dissipate over 6 years (depression-by-time estimate: p = .011). Finally, subjects depressed both at baseline and at 6-year follow up had consistently lower n-3 PUFA levels over the entire follow-up as compared to those who had never been depressed. Change in depressive disorders across waves was not consistently accompanied by change in n-3 PUFA levels over time.
No data on intermediate time points and EPA levels were available.
Despite significant cross-sectional associations between n-3 PUFA plasma levels and depressive disorders and severity, this 6-year longitudinal study could not confirm an uni- or bidirectional association over time. The association between depression and n-3 PUFA plasma levels is unlikely to be causal.
血浆中低ω-3多不饱和脂肪酸(n-3 PUFA)水平与抑郁症之间关联的时间性仍存在疑问。为了确定这些关联的潜在本质,本研究考察了n-3 PUFA血浆水平与抑郁症及症状(存在、发作和病程)之间的双向纵向关联。
使用荷兰抑郁症与焦虑症研究(NESDA)的基线数据(n = 2912,28.6%患有当前抑郁症)和6年随访数据(n = 1966,13.0%患有当前抑郁症)。抑郁症的诊断和症状基于精神科访谈和自我报告问卷。n-3 PUFA水平(总脂肪酸比例(mmol%))通过核磁共振评估。
利用两波数据,与健康对照相比,抑郁症患者的n-3 PUFA水平较低(β = -0.047,标准误 = 0.011,p <.001)。然而,基线n-3 PUFA水平与随后6年抑郁症状的变化、抑郁症的发作或缓解并无一致关联。此外,抑郁和非抑郁参与者在基线时检测到的n-3 PUFA水平差异在6年中趋于消失(抑郁与时间的估计值:p = 0.011)。最后,与从未抑郁的人相比,在基线和6年随访时均抑郁的受试者在整个随访期间的n-3 PUFA水平始终较低。各波次抑郁症的变化并未始终伴随着n-3 PUFA水平随时间的变化。
没有中间时间点和二十碳五烯酸(EPA)水平的数据。
尽管n-3 PUFA血浆水平与抑郁症及严重程度之间存在显著的横断面关联,但这项6年的纵向研究无法证实随时间的单向或双向关联。抑郁症与n-3 PUFA血浆水平之间的关联不太可能是因果关系。